Factors influencing caspofungin plasma concentrations in kidney transplant patients with high incidence of invasive fungal infections.
Qianting YangTao ZhangDan ZhaoYing ZhangYuzhu DongDan SunQian DuJing ZhengHaidong LuYa-Lin DongPublished in: Journal of clinical pharmacy and therapeutics (2019)
This is an uncontrolled observational study of caspofungin as prophylaxis or treatment for IFIs in kidney transplant patients. Caspofungin could be an effective and well-tolerated option for antifungal prophylaxis and treatment in kidney transplant patients, and a number of factors could influence caspofungin Cmin in these patients.